Clincosm LogoSign in Get a demo

Transitional Cell Carcinoma

Showing 1 - 25 of 37
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Transitional Cell Carcinoma Trial in New York (TICE®-strain BCG, NY-ESO-1 protein, sargramostim)

Completed
Has Results
  • Transitional Cell Carcinoma
  • TICE®-strain BCG
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

Recruiting
  • Acinar Cell Carcinoma
  • +93 more
  • Biospecimen Collection
  • +2 more
  • Birmingham, Alabama
  • +998 more
Aug 23, 2022

Metastatic Urothelial Carcinoma, Transitional Cell Carcinoma, Unresectable Transitional Cell Carcinoma Trial in Houston

Active, not recruiting
  • Metastatic Urothelial Carcinoma
  • +2 more
  • Doxorubicin Hydrochloride
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Transitional Cell Carcinoma Trial in New Haven (Pembrolizumab and Ramucirumab)

Withdrawn
  • Transitional Cell Carcinoma
  • Pembrolizumab and Ramucirumab
  • New Haven, Connecticut
    Yale University
Feb 18, 2022

Urothelial Carcinoma, Bladder Cancer, Transitional Cell Carcinoma Trial in United States (nab-paclitaxel, Gemcitabine)

Terminated
Has Results
  • Urothelial Carcinoma
  • +2 more
  • Fort Myers, Florida
  • +4 more
Dec 15, 2021

Transitional Cell Carcinoma, Advanced Cancer, Metastatic Cancer Trial in Austria, Germany (Nivolumab/Ipilimumab)

Active, not recruiting
  • Transitional Cell Carcinoma
  • +2 more
  • Nivolumab/Ipilimumab
  • Graz, Austria
  • +26 more
Nov 2, 2021

Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib

Recruiting
  • Bladder Cancer
  • +12 more
  • Raleigh, North Carolina
    xCures Virtual Site
Sep 20, 2021

Transitional Cell Carcinoma Trial in Winston-Salem (other, drug, biological)

Active, not recruiting
  • Transitional Cell Carcinoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Aug 30, 2021

Transitional Cell Carcinoma, Bladder Cancer Trial (Bintrafusp alfa)

Not yet recruiting
  • Transitional Cell Carcinoma
  • Bladder Cancer
  • Bintrafusp alfa
  • (no location specified)
May 6, 2021

Transitional Cell Carcinoma, Bladder Cancer, Carcinoma in Situ Trial in United States (CG0070 Adenovirus Vector, Control Arm:

Terminated
  • Transitional Cell Carcinoma
  • +3 more
  • CG0070 Adenovirus Vector
  • Control Arm: Quadruple Choice
  • Phoenix, Arizona
  • +6 more
Apr 12, 2021

Urinary Bladder Tumor, Transitional Cell Carcinoma, Urogenital Tumors Trial in Hall In Tirol, Salzburg (Bipolar transurethral

Recruiting
  • Urinary Bladder Neoplasm
  • +4 more
  • Bipolar transurethral resection of bladder tumor (TURBT)
  • Bipolar transurethral plasma kinetic vaporization of bladder tumor (PKVBT)
  • Hall In Tirol, Austria
  • +1 more
Mar 19, 2021

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo

Recruiting
  • Cancer, All Types
  • +44 more
    • Gainesville, Georgia
      Specicare
    Dec 2, 2020

    Carcinoma, Transitional Cell Carcinoma, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Israel, United States

    Withdrawn
    • Carcinoma
    • +2 more
    • UGN-101 instillations
    • Los Angeles, California
    • +4 more
    May 5, 2020

    Transitional Cell Carcinoma, Bladder Carcinoma, Urothelial Carcinoma Trial in United States (Everolimus, Paclitaxel)

    Terminated
    • Transitional Cell Carcinoma
    • +2 more
    • Birmingham, Alabama
    • +10 more
    Oct 14, 2019

    Detecting Transitional Cell Carcinoma From Haematuria

    Completed
    • Transitional Cell Carcinoma
      • Hull, United Kingdom
        Castle Hill Hospital
      Jul 26, 2019

      Bladder Cancer, Transitional Cell Carcinoma Trial in Milano (Alisertib, Paclitaxel, Placebo)

      Completed
      • Bladder Cancer
      • Transitional Cell Carcinoma
      • Milano, Mi, Italy
        Fondazione IRCCS Istituto Nazionale dei Tumori
      Apr 9, 2019

      Transitional Cell Carcinoma Trial in Birmingham (Cabazitaxel, Best Supportive Care)

      Completed
      • Transitional Cell Carcinoma
      • Birmingham, United Kingdom
        University Hospitals Birmingham
      Nov 30, 2018

      Transitional Cell Carcinoma, Bladder Cancer Trial in Boston (Docetaxel, vandetanib, Placebo)

      Completed
      Has Results
      • Transitional Cell Carcinoma
      • Bladder Cancer
      • Boston, Massachusetts
      • +2 more
      Aug 20, 2018

      Infiltrating Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma, Transitional Cell Carcinoma Trial (procedure,

      Withdrawn
      • Infiltrating Bladder Urothelial Carcinoma
      • +2 more
      • Biopsy
      • +4 more
      • (no location specified)
      Dec 28, 2017

      Carcinoma in Situ, Transitional Cell Carcinoma, Non-muscle Invasive Bladder Cancer Trial in United States (VALSTAR - Maintenance

      Terminated
      Has Results
      • Carcinoma in Situ
      • +2 more
      • VALSTAR - Maintenance Therapy
      • No Maintenance treatment ( Standard of Care)
      • Phoenix, Arizona
      • +5 more
      Sep 7, 2017

      Bladder Cancer, Ureter Cancer, Urethral Cancer Trial in Korea, Republic of (Treatment duration of cisplatin based chemo)

      Unknown status
      • Bladder Cancer
      • +3 more
      • Treatment duration of cisplatin based chemotherapy
      • Yangsan, Gyeongsangnam-do, Korea, Republic of
      • +18 more
      Sep 23, 2017

      Bladder Cancer, Ureter Cancer, Transitional Cell Carcinoma Trial in Korea, Republic of (pemetrexed, Folic Acid, Vitamin B12

      Unknown status
      • Bladder Cancer
      • +2 more
      • Anyang, Korea, Republic of
      • +20 more
      Jun 18, 2017

      Renal Cell Carcinoma, Renal Cysts, Transitional Cell Carcinoma Trial in New Delhi (Standard multiphase CT, split bolus Dual

      Completed
      • Renal Cell Carcinoma
      • +3 more
      • Standard multiphase CT
      • split bolus Dual energy CT
      • New Delhi, Delhi, India
        All India Institute of Medical Sciences
      Apr 26, 2017

      Melanoma, Sarcoma, Gastrointestinal Stromal Tumor (GIST) Trial in Frankfurt (Mixed bacterial vaccine)

      Completed
      Has Results
      • Melanoma
      • +8 more
      • Mixed bacterial vaccine
      • Frankfurt, Germany
        Krankenhaus Nordwest
      Nov 10, 2016

      Transitional Cell Carcinoma Trial in Canada (Paclitaxel)

      Completed
      • Transitional Cell Carcinoma
      • Hamilton, Ontario, Canada
      • +4 more
      Oct 14, 2016